TREM2 and amyloidosis: In APP23, 5xFAD, and APPPS1 models with robust amyloid pathology but an absence of tau pathology, TREM2 expression levels are increased in microglia and other myeloid cells surrounding amyloid plaques [86, 88, 89, 90].